Rh(D) haemolytic disease of the newborn: the changing scene.
作者信息
Urbaniak S J
出版信息
Br Med J (Clin Res Ed). 1985 Jul 6;291(6487):4-6. doi: 10.1136/bmj.291.6487.4.
Abstract
摘要
相似文献
1
Rh(D) haemolytic disease of the newborn: the changing scene.
Br Med J (Clin Res Ed). 1985 Jul 6;291(6487):4-6. doi: 10.1136/bmj.291.6487.4.
2
Rhesus haemolytic disease.
Arch Dis Child. 1992 Jan;67(1 Spec No):65-8. doi: 10.1136/adc.67.1_spec_no.65.
3
Transfusion support in the management of immune haemolytic disorders.
Clin Haematol. 1984 Feb;13(1):167-83.
4
Haemolytic disease of newborn.
Indian J Pediatr. 2001 Feb;68(2):167-72. doi: 10.1007/BF02722039.
5
Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient.
Transfusion. 1990 Feb;30(2):175-83. doi: 10.1046/j.1537-2995.1990.30290162907.x.
6
Immunohaematological aspects of modern prenatal, maternal and newborn care.
Ann Immunol Hung. 1972;16(0):277-82.
7
Prevention of haemolytic disease of the newborn due to anti-D.
Br Med J (Clin Res Ed). 1981 Jul 11;283(6284):142. doi: 10.1136/bmj.283.6284.142.
8
The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
CMAJ. 1986 Jun 1;134(11):1259-61.
9
Management of pregnancy complicated by Rh-immunization. Review with respect to own investigations and results.
Pathologica. 1972 Mar-Apr;64(929):139-48.
10
[Rh sensitization].
Rad Med Fak Zagrebu. 1970;18(2):89-105.
引用本文的文献
1
The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
CMAJ. 1986 Jun 1;134(11):1259-61.
2
Expression of a human monoclonal anti-(rhesus D) Fab fragment in Escherichia coli with the use of bacteriophage lambda vectors.
Biochem J. 1991 Jul 15;277 ( Pt 2)(Pt 2):561-3. doi: 10.1042/bj2770561.
本文引用的文献
1
Intrauterine fetal transfusions: Winnipeg 1982.
Obstet Gynecol. 1983 Feb;61(2):203-9.
2
Intensive plasma exchange in the management of severe Rh disease.
Br J Haematol. 1980 Aug;45(4):621-31. doi: 10.1111/j.1365-2141.1980.tb07185.x.
3
Prediction of the outcome of rhesus haemolytic disease of the newborn: additional information using an ADCC assay.
Vox Sang. 1984;46(5):323-9. doi: 10.1111/j.1423-0410.1984.tb00093.x.
4
Fetal blood group studies during mid-trimester pregnancy and the management of severe isoimmunization.
Prenat Diagn. 1983 Jan;3(1):41-6. doi: 10.1002/pd.1970030109.
5
The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions.
Am J Obstet Gynecol. 1984 Nov 15;150(6):769-74. doi: 10.1016/0002-9378(84)90683-5.
6
Changes in the management of severely Rh-immunized patients.
Am J Obstet Gynecol. 1984 Jun 1;149(3):336-41. doi: 10.1016/0002-9378(84)90234-5.
7
Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.
Br Med J (Clin Res Ed). 1982 Jul 31;285(6338):327-9. doi: 10.1136/bmj.285.6338.327.
8
Antenatal anti-D immunoglobulin.
Lancet. 1983 Sep 24;2(8352):734.
9
The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae.
Lancet. 1983 Jul 30;2(8344):244-6. doi: 10.1016/s0140-6736(83)90232-5.
10
Production of human monoclonal antibody to rhesus D antigen.
Lancet. 1983 Feb 19;1(8321):386-8. doi: 10.1016/s0140-6736(83)91502-7.
Zotero 插件